Johanna Vappiani
GlaxoSmithKline (Poland)(PL)Diabetesinstitut Heidelberg(DE)GlaxoSmithKline (Germany)(DE)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Viral Infectious Diseases and Gene Expression in Insects, Protein Degradation and Inhibitors, Metabolomics and Mass Spectrometry Studies, Microbial Metabolic Engineering and Bioproduction
Most-Cited Works
- → Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation(2020)416 cited
- → Bioaccumulation of therapeutic drugs by human gut bacteria(2021)291 cited
- → Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis(2018)223 cited
- → Identifying drug targets in tissues and whole blood with thermal-shift profiling(2020)188 cited
- → Click chemistry enables preclinical evaluation of targeted epigenetic therapies(2017)141 cited
- → A Modular Probe Strategy for Drug Localization, Target Identification and Target Occupancy Measurement on Single Cell Level(2016)85 cited
- → New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids